Drug reps are very negative in their posts. Also insiders are selling at this level. I think shares are going to go down more. TMC 435 has no anemia or rash issue and can be given once daily and approval is thought to be in Mid 2013. Any negative trial news for VX 222 or VX 787 and this thing can go below $26.50 in no time in my opinion.
If cafepharma is your source for investment decisions......well good luck with that. It's a forum for immature sales reps to whine about their last pay check and yell at the competition. The insider sales are all triggered automatically as they are officers of the company.